These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23541840)

  • 1. Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART).
    Morabito K; Kantor R; Tai W; Schreier L; Tripathi A
    J Mol Diagn; 2013 May; 15(3):401-12. PubMed ID: 23541840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets.
    Wang J; Tai W; Angione SL; John AR; Opal SM; Artenstein AW; Tripathi A
    J Clin Microbiol; 2013 Oct; 51(10):3324-30. PubMed ID: 23903546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a real-time nucleic acid sequence-based amplification assay using molecular beacons for detection of human immunodeficiency virus type 1.
    McClernon DR; Vavro C; St Clair M
    J Clin Microbiol; 2006 Jun; 44(6):2280-2. PubMed ID: 16757640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.
    Coovadia A; Hunt G; Abrams EJ; Sherman G; Meyers T; Barry G; Malan E; Marais B; Stehlau R; Ledwaba J; Hammer SM; Morris L; Kuhn L
    Clin Infect Dis; 2009 Feb; 48(4):462-72. PubMed ID: 19133804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
    Ziemniak C; George-Agwu A; Moss WJ; Ray SC; Persaud D
    J Virol Methods; 2006 Sep; 136(1-2):238-47. PubMed ID: 16828172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
    AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    Panpradist N; Beck IA; Ruth PS; Ávila-Ríos S; García-Morales C; Soto-Nava M; Tapia-Trejo D; Matías-Florentino M; Paz-Juarez HE; Del Arenal-Sanchez S; Reyes-Terán G; Lutz BR; Frenkel LM
    AIDS; 2020 Jul; 34(9):1331-1338. PubMed ID: 32205723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings.
    Iqbal HS; Balakrishnan P; Cecelia AJ; Solomon S; Kumarasamy N; Madhavan V; Murugavel KG; Ganesh AK; Solomon SS; Mayer KH; Crowe SM
    J Med Microbiol; 2007 Dec; 56(Pt 12):1611-1614. PubMed ID: 18033828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.
    Church JD; Jones D; Flys T; Hoover D; Marlowe N; Chen S; Shi C; Eshleman JR; Guay LA; Jackson JB; Kumwenda N; Taha TE; Eshleman SH
    J Mol Diagn; 2006 Sep; 8(4):430-2; quiz 527. PubMed ID: 16931582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.
    Gianotti N; Galli L; Boeri E; Maillard M; Serra G; Ratti D; Gallotta G; Vacchini D; Tremolada Y; Lazzarin A; Clementi M; Castagna A
    New Microbiol; 2005 Oct; 28(4):319-26. PubMed ID: 16386016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
    Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
    PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restriction fragment mass polymorphism (RFMP) analysis based on MALDI-TOF mass spectrometry for detecting antiretroviral resistance in HIV-1 infected patients.
    Lee JH; Hachiya A; Shin SK; Lee J; Gatanaga H; Oka S; Kirby KA; Ong YT; Sarafianos SG; Folk WR; Yoo W; Hong SP; Kim SO
    Clin Microbiol Infect; 2013 Jun; 19(6):E263-70. PubMed ID: 23480551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O.
    de Baar MP; van Dooren MW; de Rooij E; Bakker M; van Gemen B; Goudsmit J; de Ronde A
    J Clin Microbiol; 2001 Apr; 39(4):1378-84. PubMed ID: 11283059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection.
    Toni TA; Asahchop EL; Moisi D; Ntemgwa M; Oliveira M; Masquelier B; Brenner BG; Wainberg MA
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1670-2. PubMed ID: 19171798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an allele-specific PCR to clinical HIV genotyping samples detects additional K103N mutations in both therapy naïve and experienced patients.
    Carr JM; Green T; Shaw D; Daly L; Hart W; Ratcliff R; Higgins G; Burrell CJ; Li P; Qiao M
    J Med Virol; 2009 Dec; 81(12):1983-90. PubMed ID: 19856473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays for the determination of HIV-1 load in semen: a review of indications, methods and performance in vitro.
    Chan DJ; McNally L
    Curr HIV Res; 2008 May; 6(3):182-8. PubMed ID: 18473781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal profiling of HIV-1 pol for genotypic study and resistance analysis across subtypes.
    Nie T; Detorio M; Schinazi RF
    Antivir Ther; 2011; 16(8):1267-75. PubMed ID: 22155908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.